Literature DB >> 33492440

The triglycerides and glucose index is strongly associated with hepatic steatosis in children with overweight or obesity.

Luis E Simental-Mendía1, César Javier Ortega-Pacheco2, Elvira García-Guerrero2, María Alejandra Sicsik-Aragón1, Fernando Guerrero-Romero1, Gerardo Martínez-Aguilar3.   

Abstract

Given the worldwide increase prevalence of overweight, obesity, and nonalcoholic fatty liver disease (NAFLD), the objective of this study was to evaluate whether the triglycerides and glucose (TyG) index is associated with hepatic steatosis in children with overweight or obesity. Apparently healthy children aged 5‑17 years were included and allocated into the groups with and without hepatic steatosis. The TyG index was calculated as Ln [fasting triglycerides (mg/dL) × fasting glucose (mg/dL)]/2. Hepatic steatosis was diagnosed by ultrasonography. A total of 177 children, 66 (37.3%) girls and 111 (62.7%) boys, were included in the study. According to the hepatic ultrasonography, they were allocated into the groups with (n = 100) and without (n = 77) hepatic steatosis. The adjusted analysis by gender, body mass index, and waist circumference revealed that HDL-C (OR 0.96; 95% CI: 0.93-0.99), triglycerides (OR 1.005; 95% CI: 1.001-1.009), AST (OR 1.03; 95% CI: 1.008-1.07), ALT (OR 1.03; 95% CI: 1.01-1.05), and TyG index (OR 4.07; 95% CI: 1.26-13.15) remained associated with hepatic steatosis.
Conclusion: Compared to other biochemical markers, the TyG index is highly associated with the presence of fatty liver in children with overweight and obesity. What is known: • The triglycerides and glucose (TyG) index is effective in predicting high risk for incident nonalcoholic fatty liver disease (NAFLD) in adults. What is new: • Compared to other biochemical markers, the TyG index is highly associated with the presence of fatty liver in children with overweight or obesity. • The triglycerides and glucose index may be a useful tool to detect children at high risk of fatty liver.

Entities:  

Keywords:  Children; Glucose; Hepatic steatosis; Triglycerides; TyG index

Year:  2021        PMID: 33492440     DOI: 10.1007/s00431-021-03951-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  34 in total

1.  The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp.

Authors:  Fernando Guerrero-Romero; Luis E Simental-Mendía; Manuel González-Ortiz; Esperanza Martínez-Abundis; María G Ramos-Zavala; Sandra O Hernández-González; Omar Jacques-Camarena; Martha Rodríguez-Morán
Journal:  J Clin Endocrinol Metab       Date:  2010-05-19       Impact factor: 5.958

Review 2.  Nonalcoholic fatty liver disease and bariatric surgery in adolescents.

Authors:  AiXuan Holterman; Juan Gurria; Smita Tanpure; Nerina DiSomma
Journal:  Semin Pediatr Surg       Date:  2013-10-31       Impact factor: 2.754

3.  Insulin sensitivity indices: fasting versus glucose-stimulated ındices in pediatric non-alcoholic fatty liver disease.

Authors:  B Ozhan; B Ersoy; S Kiremitci; M Ozkol; F Taneli
Journal:  Eur Rev Med Pharmacol Sci       Date:  2015-09       Impact factor: 3.507

Review 4.  Non-alcoholic fatty liver and metabolic syndrome in children: a vicious circle.

Authors:  Arianna Alterio; Anna Alisi; Daniela Liccardo; Valerio Nobili
Journal:  Horm Res Paediatr       Date:  2014-10-15       Impact factor: 2.852

5.  MRI steatosis grading: development and initial validation of a color mapping system.

Authors:  Aliya Qayyum; Michelle Nystrom; Susan M Noworolski; Philip Chu; Arpan Mohanty; Raphael Merriman
Journal:  AJR Am J Roentgenol       Date:  2012-03       Impact factor: 3.959

Review 6.  Advances in pediatric nonalcoholic fatty liver disease.

Authors:  Rohit Loomba; Claude B Sirlin; Jeffrey B Schwimmer; Joel E Lavine
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

7.  Elevated serum ALT in children presenting to the emergency unit: Relationship with NAFLD.

Authors:  V Nobili; A Reale; A Alisi; G Morino; I Trenta; M Pisani; M Marcellini; U Raucci
Journal:  Dig Liver Dis       Date:  2009-04-11       Impact factor: 4.088

Review 8.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

9.  The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects.

Authors:  Luis E Simental-Mendía; Martha Rodríguez-Morán; Fernando Guerrero-Romero
Journal:  Metab Syndr Relat Disord       Date:  2008-12       Impact factor: 1.894

Review 10.  The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis.

Authors:  Emma L Anderson; Laura D Howe; Hayley E Jones; Julian P T Higgins; Debbie A Lawlor; Abigail Fraser
Journal:  PLoS One       Date:  2015-10-29       Impact factor: 3.240

View more
  3 in total

1.  Comparison of the Modified TyG Indices and Other Parameters to Predict Non-Alcoholic Fatty Liver Disease in Youth.

Authors:  Kyungchul Song; Hae Won Lee; Han Saem Choi; Goeun Park; Hye Sun Lee; Su Jin Kim; Myeongseob Lee; Junghwan Suh; Ahreum Kwon; Ho-Seong Kim; Hyun Wook Chae
Journal:  Biology (Basel)       Date:  2022-04-29

2.  Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study.

Authors:  Zhi Liu; He He; Yuzhao Dai; Lidan Yang; Shenling Liao; Zhenmei An; Shuangqing Li
Journal:  Lipids Health Dis       Date:  2022-06-25       Impact factor: 4.315

3.  Association between triglyceride glucose index, coronary artery calcification and multivessel coronary disease in Chinese patients with acute coronary syndrome.

Authors:  Jiayu Wang; Xianwei Huang; Caihua Fu; Qiping Sheng; Ping Liu
Journal:  Cardiovasc Diabetol       Date:  2022-09-16       Impact factor: 8.949

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.